Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PF-04449913 For Patients With Acute Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University of Colorado, Denver
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: April 23, 2013
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2019
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)